D010586AnatomyA11.733A15.382.680340.998501Phagocytesprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMicrobiology and ImmunologyWake Forest School of MedicineMichaelSeedsMichael C. Seeds PhD36.09003100000000-80.268028000000001138Seeds, MichaelAssistant ProfessorRaviSinghRavi N. Singh PhD36.09032400000000-80.266491000000001308Singh, RaviAssistant ProfessorKarenHaasKaren M. Haas PhD36.08919100000000-80.26677800000000539Haas, KarenAssociate Professor32188623Dyevoich AM, Haas KMMolecular cancer therapeuticsDyevoich AM, Haas KM. Type I IFN, Ly6C+ cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination. Mol Cancer Ther. 2020 06; 19(6):1232-1242.Mol Cancer Ther2020-03-18T00:00:002020Type I IFN, Ly6C+ cells, and Phagocytes Support Suppression of Peritoneal Carcinomatosis Elicited by a TLR and CLR Agonist Combination.Obstetrics and Gynecology, Maternal FetalWake Forest Institute for Regenerative Medicinetrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant Professor11929750Price MO, McPhail LC, Lambeth JD, Han CH, Knaus UG, Dinauer MCBloodPrice MO, McPhail LC, Lambeth JD, Han CH, Knaus UG, Dinauer MC. Creation of a genetic system for analysis of the phagocyte respiratory burst: high-level reconstitution of the NADPH oxidase in a nonhematopoietic system. Blood. 2002 Apr 15; 99(8):2653-61.Blood2002-04-15T00:00:002002Creation of a genetic system for analysis of the phagocyte respiratory burst: high-level reconstitution of the NADPH oxidase in a nonhematopoietic system.15210744Uchida J, Hamaguchi Y, Oliver JA, Ravetch JV, Poe JC, Haas KM, Tedder TFThe Journal of experimental medicineUchida J, Hamaguchi Y, Oliver JA, Ravetch JV, Poe JC, Haas KM, Tedder TF. The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med. 2004 Jun 21; 199(12):1659-69.J Exp Med2004-06-21T00:00:002004The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy.21502377Friggeri A, Banerjee S, Biswas S, de Freitas A, Liu G, Bierhaus A, Abraham EJournal of immunology (Baltimore, Md. : 1950)Friggeri A, Banerjee S, Biswas S, de Freitas A, Liu G, Bierhaus A, Abraham E. Participation of the receptor for advanced glycation end products in efferocytosis. J Immunol. 2011 Jun 01; 186(11):6191-8.J Immunol2011-04-18T00:00:002011Participation of the receptor for advanced glycation end products in efferocytosis.7595189Triggiani M, Oriente A, Seeds MC, Bass DA, Marone G, Chilton FHThe Journal of experimental medicineTriggiani M, Oriente A, Seeds MC, Bass DA, Marone G, Chilton FH. Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J Exp Med. 1995 Nov 01; 182(5):1181-90.J Exp Med1995-11-01T00:00:001995Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool.0.2535870.01135753research area of0.4098620.0267448subject area for